DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo


company name or ticker

Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Ce

Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

Acceleron Pharma (XLRN) Strong On High Relative Volume Today

Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders

3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't

Gilead Sciences, Celgene, and Biogen all have rock-solid financials, but none are likely to pay a dividend anytime soon.

Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape

Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Comi

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months

A Quick Look at Celgene Corporation's Drug Development Pipeline

Celgene's drug development pipeline is currently firing on all cylinders; but can it stay that way for long? Find out as we take a closer look at the experimental drugs which matter most to Celgene.

Sector Update: Health-care Stocks Higher Pre-Bell

Sector Update: Health Care

See More Articles...